Recent Articles from GlobeNewswire

JACKSONVILLE, Fla., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Newsweek and Statista have ranked Priority Tire No. 1 in the Cars, Motorcycles, & Boats category of America’s Best Online Shops 2027. This ranking evaluates 500 leading online shops across 26 categories. Last year, Priority Tire ranked 37th with a score of 7.23; this year's assessment raised that score to 8.48, moving it from 37th place to first in just twelve months.

Organizing Committee of the World Maritime Equipment Conference

Strategic acquisition of Perfectum strengthens Beeline Uzbekistan’s competitive position, expands spectrum resources and creates new opportunities for growth in 5G, broadband and digital

Partnership with Vanderbilt University and Vanderbilt Health accelerates development of the first radiomics-based test for lung nodule risk assessment

VANCOUVER, British Columbia , Oct. 19, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced that Suzanne Monahan has been appointed Senior Vice President, Commercial and General Manager, Theravance Biopharma, effective immediately. Reporting directly to Kenneth Galbraith, Chair and Chief Executive Officer of Zymeworks, Ms. Monahan will lead Zymeworks’ commercial strategy and execution for YUPELRI® (revefenacin), the first and only once-daily, nebulized long-acting muscarinic antagonist (LAMA) approved in the U.S. for the maintenance treatment of chronic obstructive pulmonary disease (COPD), following the Company’s recent acquisition of Theravance Biopharma.

SAN DIEGO, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio®” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that it has received approval from Nasdaq to transfer the listing of its securities from the Nasdaq Capital Market to the Nasdaq Global Select Market. Trading on the Nasdaq Global Select Market will commence at the open of market on October 19, 2026, under the Company’s existing ticker symbol “BLTE.”

Dubai, New York and Starbase, 19 October 2026 – VEON Ltd. (Nasdaq: VEON), a global digital operator, and Starlink Mobile today announced that more than 11 million unique VEON customers have now connected to the direct-to-device service at least once in locations where cell signal cannot reach. VEON customers can use satellite-ready apps, share location, and send messages via apps and SMS on their existing LTE compatible phones.

TAIPEI, Taiwan and SOUTH SAN FRANCISCO, Calif., Oct. 19, 2026 (GLOBE NEWSWIRE) -- TLC BioSciences Corp. (TPEx: TLC-KY; ticker: 7924; “TLC”) today announced positive topline results from its pivotal Phase 3 trial of TLC590, an investigational extended-release formulation of ropivacaine, for the management of postsurgical pain following bunionectomy. The trial met its primary endpoint, with TLC590 significantly reducing pain intensity through 72 hours after surgery compared with placebo (p=0.0024); rescue opioid consumption was also significantly lower. In a head-to-head comparison with liposomal bupivacaine, an approved long-acting local anesthetic, TLC590 also demonstrated statistically significant superiority in both pain intensity and rescue opioid consumption. The analgesic benefit of TLC590 over both comparators was maintained through 168 hours. These results support the potential of TLC590 as a single-dose, non-opioid option for durable postsurgical pain relief with reduced opioid use.

MUTSAMUDU, Comoros, Oct. 19, 2026 (GLOBE NEWSWIRE) -- MEXC, a pioneer in 0-fee digital asset trading, today announced its September 2026 platform highlights, led by expanding its traditional finance (TradFi) asset coverage to more than 10,000 assets and adding 1,000 BTC to its Guardian Fund. These developments reflect MEXC's ongoing efforts to broaden users' access to global markets and strengthen user asset protection.

Nationwide Defined Protection® Annuity 2.0 linked to American Funds® The Growth Fund of America® marked an industry first for registered index-linked annuities

Pax8 also introduces 8bot, a managed AI coworker for end-customers’ employees

Charter Member Pax8 joined by Founding Party Members CrowdStrike, Cynet, F1 Information Technologies, Lyra, Microsoft, New Charter, NinjaOne, Rev.io and Sourcepass to co-develop channel standards, accreditation and research with IT Service Providers (ITSPs)

ATEN International, the parent company of ATEN Technology, Inc., the leading provider of KVM, AV/IT connectivity, and management solutions presented TD SYNNEX with its Annual Best Sales Performance Award. This esteemed recognition celebrates the exceptional results, strong collaboration, and continuous sales momentum achieved through the powerful partnership between the two organizations.

Gree Electric Appliances, INC. of Zhuhai

Overseas Forum of the International Congress of Luobing Theory

BEIJING, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Niu Technologies (“NIU” or “the Company”) (NASDAQ: NIU), the world’s leading provider of smart urban mobility solutions, today announced that it will report its financial results for the third quarter 2026 before the U.S. market opens on Monday, November 16, 2026.

SHENZHEN, China, Oct. 19, 2026 (GLOBE NEWSWIRE) -- BYD Energy Storage has built a comprehensive after-sales service network in a multi‑tier framework: station O&M, project centers, regional centers and global headquarters.

High-Responder Target Enrichment: 2/3 of the 176 enrolled patients carry the target TNFR1 genetic variant previously linked to enhanced clinical response in Phase 2 trials

Long-standing partnership expands as tpay becomes Vodafone Qatar’s Direct Operator Billing aggregator, building on a proven track record of major digital service launches

Nantes, France, October 19, 2026 – 7:30am CEST – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), a clinical-stage biotech company dedicated to developing first-in-class therapies in immuno-oncology and immuno-inflammation, today announced the release of the abstract selected for an oral presentation at the upcoming ESMO 2026 Annual Meeting, unveiling topline results from the Combi-TED academic Phase 2 international clinical trial of Tedopi® sponsored by FoRT and evaluating Tedopi® (OSE2101), in combination with either chemotherapy or anti-PD1, as a 2nd line treatment in patients with metastatic Non-Small Cell Lung Cancer (NSCLC).

MELBOURNE, Australia and LOUVAIN-LA-NEUVE, Belgium and PARIS and INDIANAPOLIS, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) and Ekalia, a joint venture between IBA (Ion Beam Applications S.A., EURONEXT) and Framatome, today announced a collaboration to advance scalable United States (U.S.) production of astatine-211 (211At), an alpha-emitting radioisotope being investigated for targeted alpha therapy.

The Organizing Committee of the 4th Liangzhu Forum

Press release – No. 21 / 2026

FOXWELL outlines diagnostic checks for passenger cars and heavy-duty vehicles as drivers prepare for colder weather

Presentations to cover updates across Eikon’s clinical pipeline including: 

WATERTOWN, Mass., Oct. 18, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced it will host a corporate webcast to discuss topline results from the APOLLO Phase 3 trial of bitopertin in EPP. The webcast will be held on Monday, October 19, 2026 at 8:00 a.m. ET.

Houston, Oct. 18, 2026 (GLOBE NEWSWIRE) -- Sara R. Dickie, MD, has been named President of The Plastic Surgery Foundation (The PSF), an organization that supports the research, education and international activities for the American Society of Plastic Surgeons (ASPS). Dr. Dickie officially assumed her role at Plastic Surgery The Meeting, the Society’s annual scientific conference, held this year in Houston. She will complete her presidential term on Sept. 19, 2027.

Houston, Oct. 18, 2026 (GLOBE NEWSWIRE) -- Lynn A. Damitz, MD, FACS, has been named President of the American Society of Plastic Surgeons (ASPS), the world's largest organization of board-certified plastic surgeons. Dr. Damitz assumed the role during Plastic Surgery The Meeting, the Society's annual scientific conference, held this year in Houston. She will serve a one-year term through Sept. 19, 2027.

WALTHAM, Mass., Oct. 18, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company committed to developing next-generation therapies that elevate the standard in immunology by delivering more complete disease control, greater durability, and a simpler treatment experience for patients, today announced presentations at United European Gastroenterology Week (UEGW) 2026 in Barcelona. The presentations include the first scientific congress presentation of clinical data across all three of Spyre’s IBD antibodies—SPY001 (anti-α4β7), SPY002 (anti-TL1A), and SPY003 (anti-IL-23)—which are now being tested as monotherapies and pairwise combinations in the SKYLINE study, as well as new preclinical data demonstrating additive efficacy of these complementary mechanisms.

NEW YORK, Oct. 18, 2026 (GLOBE NEWSWIRE) --

NEW YORK, Oct. 18, 2026 (GLOBE NEWSWIRE) --

NEW YORK, Oct. 18, 2026 (GLOBE NEWSWIRE) --

NEW YORK, Oct. 18, 2026 (GLOBE NEWSWIRE) --

In recognition of the largest donation ever made to the Hebrew University, the historic Mount Scopus campus will be named The Alina and John Paulson Campus, Mount Scopus, Jerusalem

CGTN published an article exploring how Ulanqab, a city in north China, is transforming its natural advantages into new growth drivers amid the global AI boom while balancing technological advancement and economic growth with ecological conservation to chart a path toward greener development.

"Good Giving" offers donors the opportunity to pay it forward with Donor Rewards

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Taboola.com (TBLA) To Contact Him Directly To Discuss Their Options

If you purchased or acquired AEVEX Class A common stock: (1) pursuant to the registration statement and prospectus issued in connection with the Company's April 17, 2026 initial public offering ("IPO"); or (ii) between April 17, 2026, and June 4, 2026 and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at investigations@bespc.com or by telephone at (212) 355-4648.

If you purchased or acquired Fractyl securities between January 13, 2025 and January 29, 2026 and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at investigations@bespc.com or by telephone at (212) 355-4648.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In GoDaddy (GDDY) To Contact Him Directly To Discuss Their Options

NEW YORK, Oct. 17, 2026 (GLOBE NEWSWIRE) --

NEW YORK, Oct. 17, 2026 (GLOBE NEWSWIRE) --

NEW YORK, Oct. 17, 2026 (GLOBE NEWSWIRE) --

WUHU, China, Oct. 17, 2026 (GLOBE NEWSWIRE) -- AiMOGA Robotics will unveil Mobo, its first consumer-grade family companion humanoid robot, in Wuhu, Anhui, on October 21, with global pre-orders opening the same day. The launch is part of the 2026 Chery International User Summit, highlighting AiMOGA’s latest progress in bringing embodied intelligence into everyday life.

Telling stories of poverty reduction and shared development from a local perspective

ABU DHABI, United Arab Emirates, Oct. 16, 2026 (GLOBE NEWSWIRE) -- NIP Group Inc. (“NIP Group” or the “Company”) (NASDAQ: NIPG), a leading digital entertainment company, today announced that the Company’s extraordinary general meeting of shareholders (the “EGM”) was held in Hong Kong on October 16, 2026. During the EGM, the following proposed resolutions were duly passed:

SAN JOSE, Calif., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Blaize Holdings, Inc. (NASDAQ: BZAI, NASDAQ: BZAIW) (“Blaize,” the “Company,” “we,” “us,” and “our”), a leader in programmable, energy-efficient AI computing, announced today that its Board of Directors declared a dividend of one one-thousandth of a share of newly designated Series B Preferred Stock, par value $0.0001 per share, for each outstanding share of Blaize common stock held of record on October 26, 2026. The outstanding shares of Series B Preferred Stock will vote together with the outstanding shares of the Company’s common stock as a single class exclusively with respect to any proposal to adopt an amendment to the Company’s certificate of incorporation to reclassify the outstanding shares of the Company’s common stock into a smaller number of shares of such common stock at a ratio specified in or determined in accordance with the terms of any such amendment (a “Reverse Stock Split Proposal”), as well as any proposal to adjourn any meeting of stockholders called for the purpose of voting on the foregoing matter (an “Adjournment Proposal”), and will not be entitled to vote on any other matter, except to the extent required under the Delaware General Corporation Law. Subject to certain limitations, each outstanding share of Series B Preferred Stock will have 1,000,000 votes per share (or 1,000 votes per one one-thousandth of a share of Series B Preferred Stock).

RANCHO CORDOVA, Calif., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Five Star Bancorp (Nasdaq: FSBC) (“Five Star” or the “Company”), a holding company that operates through its wholly owned banking subsidiary, Five Star Bank (the "Bank"), announced today the declaration of a cash dividend of $0.25 per share on the Company’s voting common stock. The dividend is expected to be paid on November 9, 2026, to shareholders of record as of November 2, 2026.

SINGAPORE, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Phaos Technology Holdings (Cayman) Limited (NYSE American: POAS) (“Phaos” or “the Company”), an advanced microscopy technology company headquartered in Singapore, announced that it filed its annual report on Form 20-F (the “Annual Report”) for the fiscal year ended April 30, 2026 with the U.S. Securities and Exchange Commission (the “SEC”) on August 31, 2026.

NEW YORK, Oct. 16, 2026 (GLOBE NEWSWIRE) --

Veteran industrial leader and former Tenneco CEO to lead global materials science company.

NEW YORK, Oct. 16, 2026 (GLOBE NEWSWIRE) --

BRISBANE, Calif., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that it has granted inducement to six new non-executive employees under the terms of the 2022 Employment Inducement Award Plan. The equity awards were approved on October 7, 2026, in accordance with Nasdaq Listing Rule 5635(c)(4).

VANCOUVER, British Columbia, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Atico Mining Corporation (the “Company” or “Atico”) (TSX.V: ATY | OTC: ATCMF) announces that pursuant to the Company's stock option plan, 5,162,338 incentive stock options exercisable at $0.225 per share for a period of five years have been granted to directors, officers, employees and consultants of the Company.

PHILADELPHIA, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL”) therapies for patients with cancer, today announced that on October 15, 2026 (the “Date of Grant”), the Company approved the grant of inducement stock options covering an aggregate of 111,615 shares of Iovance��s common stock to twenty-one new, non-executive employees.

CLAYMONT, Del., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Archimedes Tech SPAC Partners II Co. (Nasdaq: ATII) (“Archimedes II” or “ATII”), a publicly traded special purpose acquisition company, today announced that at the Extraordinary General Meeting (the “Meeting”) held today, October 16, 2026, ATII’s shareholders voted to approve the previously announced business combination (the “Business Combination”) between ATII and Forge Nano, Inc. (“Forge Nano”), as well as all other proposals related to the Business Combination considered and voted upon at the Meeting.

TORONTO, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Northland Power Inc. (“Northland”) (TSX: NPI) announces it will release its 2026 third quarter operating and financial results after markets close on Thursday, November 12, 2026. Northland's management will hold an earnings conference call and webcast at 9:00 a.m. Eastern Time (ET) on Friday, November 13, 2026, followed by a question-and-answer period with analysts.

CALGARY, Alberta, Oct. 16, 2026 (GLOBE NEWSWIRE) -- TC Energy Corporation (TSX, NYSE: TRP) (TC Energy or the Company) will hold a teleconference and webcast on Thursday, Nov. 5, 2026, to discuss its third quarter financial results. The event will also include an update to the Company’s financial outlook along with other developments.

FORT COLLINS, Colo., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Woodward (NASDAQ: WWD), a global leader in aerospace and industrial energy control solutions, today announced the appointment of Paxton McVoy as Executive Vice President and Chief Information Officer (CIO), effective Oct. 19, 2026. He will join the company's Executive Leadership Team, reporting directly to Chief Executive Officer Chip Blankenship.

NEW YORK, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Apollo Commercial Real Estate Finance, Inc. (the “Company”) (NYSE: ARI) today provided an update on its ongoing liquidation activities, including updates regarding the anticipated timing of delisting from the New York Stock Exchange (the “NYSE”) and the establishment of a liquidating trust for purposes of completing the wind-down process and dissolution of the Company in accordance with the Plan of Complete Liquidation and Dissolution (the “Plan”).

SHENZHEN, China, Oct. 16, 2026 (GLOBE NEWSWIRE) -- LexinFintech Holdings Ltd. (“Lexin” or the “Company”) (NASDAQ: LX), a leading technology-empowered personal financial service enabler in China, today announced that it received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) on October 14, 2026 indicating that the Company is not in compliance with the $1.00 minimum bid price requirement under the Nasdaq Listing Rules (the “Listing Rules”). Based on the closing bid price of the Company’s listed securities from September 1, 2026 to October 13, 2026, the Company has not met the minimum bid price requirement set forth in Listing Rule 5450(a)(1) during that period. The Notice is only a notification of deficiency and has no immediate effect on the listing of the Company’s American Depositary Shares (“ADS”). The Company’s ADSs will continue to trade on the Nasdaq Global Select Market at this time. The Company’s receipt of the Notice does not impact the Company’s business, operations or reporting requirements with the U.S. Securities and Exchange Commission. 

SOUTHLAKE, Texas, Oct. 16, 2026 (GLOBE NEWSWIRE) -- HealthRecon Connect, a technology-enabled Revenue Cycle Management solutions provider to U.S. healthcare organizations, today announced the successful completion of its ISO surveillance audits, retaining four ISO certifications and broadening their scope to cover more of its global delivery operations.

Severe Storms Pose Unique Electrical Hazards to Both Homes and Businesses

WALTHAM, Mass., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative therapies for patients living with autoimmune and inflammatory diseases, today announced that on October 15, 2026 (the “Grant Date”), the Compensation Committee of the Company’s Board of Directors granted an aggregate of 74,900 restricted stock units of the Company’s common stock (“RSUs”) to newly hired employees of the Company as an inducement material to such employees’ entry into employment with the Company, in accordance with Nasdaq Listing Rule 5635(c)(4) (the “Inducement Grant”).

EMERYVILLE, Calif., Oct. 16, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that on October 13, 2026, the compensation committee of the Company’s board of directors granted 13 new non-executive employees options to purchase an aggregate of 260,000 shares of the Company’s common stock and 157,600 Restricted Stock Units (RSUs). Each stock option has an exercise price per share equal to $12.36, which was the closing trading price on October 13, 2026, the date of grant. The stock options and RSUs were granted pursuant to the Company’s 2025 Employment Inducement Award Plan, as amended, under Rule 5635(c)(4) of The Nasdaq Global Market for equity grants to induce new employees to enter into employment with the Company.

PETACH TIKVA, Israel, Oct. 16, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today provided a brief business update and furnished certain preliminary unaudited financial data for the third quarter ended September 30, 2026. The preliminary figures are estimates based on currently available information, are preliminary and unaudited, and are subject to change upon completion of the Company’s financial close process, final adjustments, management review and other internal procedures, and review by its independent auditors. The Company’s final reported unaudited financial results for the third quarter of 2026 may differ materially from the preliminary figures and will be reported in a subsequent press release at a later date.

HOUSTON, Oct. 16, 2026 (GLOBE NEWSWIRE) -- HMH Holding Inc. (NASDAQ: HMH) will hold a conference call to report its third-quarter 2026 results on Thursday, November 5, 2026, at 8:00 a.m. (Central Time). HMH will issue a press release with the Company’s results after the market closes for trading on Wednesday, November 4, 2026. The call will be webcast: https://investor.hmhw.com/news-events/events     

WILMINGTON, Del., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the Chardan Healthcare Conference taking place in New York City on October 20, 2026.

TEL AVIV, Israel, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Gauzy Ltd. (Nasdaq: GAUZ) ("Gauzy" or the "Company"), a global leader in light and vision control technology, today announced that it has entered into a securities purchase agreement (the "Purchase Agreement") with a group of accredited investors led by Eyal Peso, the Company's Chief Executive Officer (collectively, the “Purchasers”), for a private investment in public equity ("PIPE") resulting in $7 million in aggregate gross proceeds (the "Offering"). Pursuant to the Purchase Agreement, the Company agreed to issue and sell 2,383,279 ordinary shares, no par value (“Ordinary Shares”), to the Purchasers at a purchase price of $2.9371 per share. In addition, in accordance with the terms of the Company’s court-approved debt settlement (the “Settlement”), 953,311 Ordinary Shares will be issued to the trustees appointed under the Settlement, Adv. Ehud Gindes and Adv. (CPA) Simion Keidar (the “Settlement Trustees”).

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In D-Wave Quantum To Contact Him Directly To Discuss Their Options

NEW YORK, Oct. 16, 2026 (GLOBE NEWSWIRE) --

HONG KONG, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Kuaishou Technology ("Kuaishou" or the "Company"; HKD Counter Stock Code: 01024 / RMB Counter Stock Code: 81024), a leading content community and social platform, today announced that Kling 4.0, the new-generation video generation model of Kling AI, officially launched on October 15.

NEW YORK, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Value Line, Inc. (NASDAQ – VALU) announced today that its Board of Directors declared on October 16, 2026 a quarterly cash dividend of $0.35 per common share, payable on November 10, 2026, to stockholders of record on October 26, 2026. The Company has 9,382,098 shares of common stock outstanding as of October 16, 2026.

NEW YORK, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against The Ensign Group, Inc. (“Ensign” or the “Company”) (NASDAQ: ENSG) on behalf of investors that purchased or otherwise acquired Ensign securities between February 10, 2022 and June 18, 2026 (the “Class Period”).